[1]
Ghosh, D. 2016. Metabolic derangements among the Schizophrenia patients consuming second generation atypical antipsychotics-Olanzapine and Aripiprazole: a randomised controlled trial. International Journal of Pharmaceutical and Biological Science Archive. 2, 6 (Aug. 2016).